2,879 results on '"M. Zimmerman"'
Search Results
2. Baseline levels of circulating galectin-1 associated with radiographic hand but not radiographic knee osteoarthritis at a two-year follow-up
- Author
-
M.L.E. Andersson, M. Zimmerman, E. Brogren, S. Bergman, L. Strindberg, E. Fryk, and P.A. Jansson
- Subjects
Osteoarthritis ,Knee ,Hand ,Galectin-1 ,Diseases of the musculoskeletal system ,RC925-935 - Abstract
Objective: We tested the potential of circulating galectin-1, interleukin (IL)-1 beta, IL-6, and tumour necrosis factor alpha (TNF alpha) levels at baseline in individuals with knee pain as biomarkers for development of radiographic knee and/or hand osteoarthritis (OA). Design: This study comprised 212 individuals with knee pain from the Halland osteoarthritis cohort (HALLOA). Clinical characteristics and serum/plasma levels of galectin-1, IL-1 beta, IL-6, and TNF alpha were measured at baseline, and knee and hand radiographs were obtained at a two-year follow-up. The predictive value of circulating inflammatory markers and clinical variables at baseline was assessed using multinominal logistic regression for those who developed radiographic OA in knees only (n = 25), in hands only (n = 40), and in both knees and hands (n = 43); the group who did not develop OA (n = 104) was used as reference. Correlations were assessed using Spearman's correlation coefficients. Results: As expected, age was identified as a risk factor for having radiographic knee and/or hand OA at the two-year follow-up. Baseline circulating galectin-1 levels did not associate with developing radiographic knee OA but associated with developing radiographic hand OA (odds ratio (OR) for a 20% increased risk: 1.14, 95% confidence interval (CI) 1.01–1.29) and both radiographic knee and hand OA (OR for a 20% increased risk: 1.18, 95% CI 1.05–1.30). However, baseline IL-1 beta, IL-6, and TNF alpha did not associate with developing radiographic knee and/or hand OA. Conclusion: Non-age adjusted circulating galectin-1 is superior to IL-6, IL-1 beta, and TNF alpha in predicting radiographic hand but not knee OA.
- Published
- 2024
- Full Text
- View/download PDF
3. Telehealth Treatment of Patients with Bipolar Depression during the COVID-19 Pandemic: Comparative Safety, Patient Satisfaction, and Effectiveness to Prepandemic In-person Treatment
- Author
-
M. Zimmerman
- Subjects
Psychiatry ,RC435-571 - Abstract
Introduction The COVID-19 pandemic prompted a transition from in-person to telehealth psychiatric treatment. There are no studies of partial hospital telehealth treatment for bipolar disorder. Objectives In the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project, we compared the effectiveness of partial hospital treatment of patients with bipolar depression treated virtually versus in-person. Methods Outcome was compared in 76 patients with bipolar depression who were treated virtually from April, 2020 to December, 2022 to 130 patients who were treated from May, 2017 to January 2020. The patients completed self-administered measures of patient satisfaction, symptoms, coping ability, functioning, and general well-being. Results In both the in-person and telehealth groups patients with bipolar depression were highly satisfied with treatment and reported a significant reduction in symptoms from admission to discharge. Both groups also reported a significant improvement in positive mental health, general well-being, coping ability, and functioning. Suicidal ideation was reduced in both groups. No patients attempted suicide. A large effect size of treatment was found in both treatment groups. The length of stay and the likelihood of staying in treatment until completion were significantly greater in the virtually treated patients. Conclusions Telehealth delivery of partial hospital level of care for patients with bipolar depression was as safe and effective as in-person treatment. Disclosure of Interest None Declared
- Published
- 2024
- Full Text
- View/download PDF
4. How Many Criteria Should be Required to Define the DSM-5 Mixed Features Specifier in Depressed Patients?
- Author
-
M. Zimmerman
- Subjects
Psychiatry ,RC435-571 - Abstract
Introduction During the past 2 decades there has been intense interest in the clinical significance of the concurrence of manic symptoms in depressed patients. DSM-5 introduced a mixed features specifier for both bipolar depression and major depressive disorder. Studies of the DSM-5 mixed features specifier have generally found a low prevalence of mixed depression. One approach towards increasing the sensitivity of the DSM-5 mixed features criteria is to lower the classification threshold. Objectives In the present study we examine the impact of lowering the DSM-5 diagnostic threshold from 3 to 2 criteria on the prevalence and validity of the DSM-5 mixed features specifier for depression. Methods Four hundred fifty-nine psychiatric patients in a depressive episode were interviewed by a trained diagnostic rater who administered semi-structured interviews including the DSM-5 Mixed Features Specifier Interview. The patients were rated on clinician rating scales of depression, anxiety and irritability, and measures of psychosocial functioning, suicidality, and family history of bipolar disorder. Results If the DSM-5 diagnostic threshold is lowered from 3 to 2 symptoms, then the prevalence of mixed features based on the DSM-5 majority of episode time frame tripled from 3.9% to 13.1% (n=60). Based on a past week time frame prevalence more than doubled from 9.4% to 22.9% (n=105) going from the 2 and 3 symptom threshold, respectively. There was no difference between the patients with 2 mixed features and patients with 0 or 1 mixed features on family history of bipolar disorder, psychosocial impairment, presence of comorbid disorders, age of onset, history of suicide attempts or psychiatric hospitalization. Conclusions The results of the present study do not support lowering the DSM-5-TR diagnostic threshold for the mixed features specifier in depressed patients from 3 to 2. Disclosure of Interest None Declared
- Published
- 2024
- Full Text
- View/download PDF
5. PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma
- Author
-
I. Garces de los Fayos Alonso, L. Zujo, I. Wiest, P. Kodajova, G. Timelthaler, S. Edtmayer, M. Zrimšek, S. Kollmann, C. Giordano, M. Kothmayer, H. A. Neubauer, S. Dey, M. Schlederer, B. S. Schmalzbauer, T. Limberger, C. Probst, O. Pusch, S. Högler, S. Tangermann, O. Merkel, A. I. Schiefer, C. Kornauth, N. Prutsch, M. Zimmerman, B. Abraham, J. Anagnostopoulos, L. Quintanilla-Martinez, S. Mathas, P. Wolf, D. Stoiber, P. B. Staber, G. Egger, W. Klapper, W. Woessmann, T. A. Look, P. Gunning, S. D. Turner, R. Moriggl, S. Lagger, and L. Kenner
- Subjects
ALCL ,PDGFRβ ,STAT3 ,STAT5A ,STAT5B ,NPM-ALK ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Anaplastic large cell lymphoma (ALCL) is an aggressive non-Hodgkin T cell lymphoma commonly driven by NPM-ALK. AP-1 transcription factors, cJUN and JUNb, act as downstream effectors of NPM-ALK and transcriptionally regulate PDGFRβ. Blocking PDGFRβ kinase activity with imatinib effectively reduces tumor burden and prolongs survival, although the downstream molecular mechanisms remain elusive. Methods and results In a transgenic mouse model that mimics PDGFRβ-driven human ALCL in vivo, we identify PDGFRβ as a driver of aggressive tumor growth. Mechanistically, PDGFRβ induces the pro-survival factor Bcl-xL and the growth-enhancing cytokine IL-10 via STAT5 activation. CRISPR/Cas9 deletion of both STAT5 gene products, STAT5A and STAT5B, results in the significant impairment of cell viability compared to deletion of STAT5A, STAT5B or STAT3 alone. Moreover, combined blockade of STAT3/5 activity with a selective SH2 domain inhibitor, AC-4-130, effectively obstructs tumor development in vivo. Conclusions We therefore propose PDGFRβ as a novel biomarker and introduce PDGFRβ-STAT3/5 signaling as an important axis in aggressive ALCL. Furthermore, we suggest that inhibition of PDGFRβ or STAT3/5 improve existing therapies for both previously untreated and relapsed/refractory ALK+ ALCL patients.
- Published
- 2022
- Full Text
- View/download PDF
6. Search for Continuous and Transient Neutrino Emission Associated with IceCube’s Highest-energy Tracks: An 11 yr Analysis
- Author
-
R. Abbasi, M. Ackermann, J. Adams, S. K. Agarwalla, J. A. Aguilar, M. Ahlers, J. M. Alameddine, N. M. Amin, K. Andeen, G. Anton, C. Argüelles, Y. Ashida, S. Athanasiadou, S. N. Axani, X. Bai, A. Balagopal V., M. Baricevic, S. W. Barwick, V. Basu, R. Bay, J. J. Beatty, J. Becker Tjus, J. Beise, C. Bellenghi, C. Benning, S. BenZvi, D. Berley, E. Bernardini, D. Z. Besson, E. Blaufuss, S. Blot, F. Bontempo, J. Y. Book, C. Boscolo Meneguolo, S. Böser, O. Botner, J. Böttcher, E. Bourbeau, J. Braun, B. Brinson, J. Brostean-Kaiser, R. T. Burley, R. S. Busse, D. Butterfield, M. A. Campana, K. Carloni, E. G. Carnie-Bronca, S. Chattopadhyay, N. Chau, C. Chen, Z. Chen, D. Chirkin, S. Choi, B. A. Clark, S. Coenders, A. Coleman, G. H. Collin, A. Connolly, J. M. Conrad, P. Coppin, P. Correa, D. F. Cowen, P. Dave, C. De Clercq, J. J. DeLaunay, D. Delgado, S. Deng, K. Deoskar, A. Desai, P. Desiati, K. D. de Vries, G. de Wasseige, T. DeYoung, A. Diaz, J. C. Díaz-Vélez, M. Dittmer, A. Domi, H. Dujmovic, M. A. DuVernois, T. Ehrhardt, A. Eimer, P. Eller, E. Ellinger, S. El Mentawi, D. Elsässer, R. Engel, H. Erpenbeck, J. Evans, P. A. Evenson, K. L. Fan, K. Fang, K. Farrag, A. R. Fazely, A. Fedynitch, N. Feigl, S. Fiedlschuster, C. Finley, L. Fischer, D. Fox, A. Franckowiak, A. Fritz, P. Fürst, J. Gallagher, E. Ganster, A. Garcia, L. Gerhardt, A. Ghadimi, C. Glaser, T. Glauch, T. Glüsenkamp, N. Goehlke, J. G. Gonzalez, S. Goswami, D. Grant, S. J. Gray, O. Gries, S. Griffin, S. Griswold, K. M. Groth, C. Günther, P. Gutjahr, C. Haack, A. Hallgren, R. Halliday, L. Halve, F. Halzen, H. Hamdaoui, M. Ha Minh, K. Hanson, J. Hardin, A. A. Harnisch, P. Hatch, A. Haungs, K. Helbing, J. Hellrung, F. Henningsen, L. Heuermann, N. Heyer, S. Hickford, A. Hidvegi, C. Hill, G. C. Hill, K. D. Hoffman, S. Hori, K. Hoshina, W. Hou, T. Huber, K. Hultqvist, M. Hünnefeld, R. Hussain, K. Hymon, S. In, A. Ishihara, M. Jacquart, O. Janik, M. Jansson, G. S. Japaridze, M. Jeong, M. Jin, B. J. P. Jones, N. Kamp, D. Kang, W. Kang, X. Kang, A. Kappes, D. Kappesser, L. Kardum, T. Karg, M. Karl, A. Karle, A. Katil, U. Katz, M. Kauer, J. L. Kelley, A. Khatee Zathul, A. Kheirandish, J. Kiryluk, S. R. Klein, A. Kochocki, R. Koirala, H. Kolanoski, T. Kontrimas, L. Köpke, C. Kopper, D. J. Koskinen, P. Koundal, M. Kovacevich, M. Kowalski, T. Kozynets, J. Krishnamoorthi, K. Kruiswijk, E. Krupczak, A. Kumar, E. Kun, N. Kurahashi, N. Lad, C. Lagunas Gualda, M. Lamoureux, M. J. Larson, S. Latseva, F. Lauber, J. P. Lazar, J. W. Lee, K. Leonard DeHolton, A. Leszczyńska, M. Lincetto, Q. R. Liu, M. Liubarska, E. Lohfink, C. Love, C. J. Lozano Mariscal, L. Lu, F. Lucarelli, W. Luszczak, Y. Lyu, J. Madsen, K. B. M. Mahn, Y. Makino, E. Manao, S. Mancina, W. Marie Sainte, I. C. Mariş, S. Marka, Z. Marka, M. Marsee, I. Martinez-Soler, R. Maruyama, F. Mayhew, T. McElroy, F. McNally, J. V. Mead, K. Meagher, S. Mechbal, A. Medina, M. Meier, Y. Merckx, L. Merten, J. Micallef, J. Mitchell, T. Montaruli, R. W. Moore, Y. Morii, R. Morse, M. Moulai, T. Mukherjee, R. Naab, R. Nagai, M. Nakos, U. Naumann, J. Necker, A. Negi, M. Neumann, H. Niederhausen, M. U. Nisa, A. Noell, A. Novikov, S. C. Nowicki, A. Obertacke Pollmann, V. O’Dell, M. Oehler, B. Oeyen, A. Olivas, R. Orsoe, J. Osborn, E. O’Sullivan, H. Pandya, N. Park, G. K. Parker, E. N. Paudel, L. Paul, C. Pérez de los Heros, J. Peterson, S. Philippen, A. Pizzuto, M. Plum, A. Pontén, Y. Popovych, M. Prado Rodriguez, B. Pries, R. Procter-Murphy, G. T. Przybylski, C. Raab, J. Rack-Helleis, K. Rawlins, Z. Rechav, A. Rehman, P. Reichherzer, G. Renzi, E. Resconi, S. Reusch, W. Rhode, B. Riedel, A. Rifaie, E. J. Roberts, S. Robertson, S. Rodan, G. Roellinghoff, M. Rongen, C. Rott, T. Ruhe, L. Ruohan, D. Ryckbosch, I. Safa, J. Saffer, D. Salazar-Gallegos, P. Sampathkumar, S. E. Sanchez Herrera, A. Sandrock, M. Santander, S. Sarkar, J. Savelberg, P. Savina, M. Schaufel, H. Schieler, S. Schindler, L. Schlickmann, B. Schlüter, F. Schlüter, N. Schmeisser, T. Schmidt, J. Schneider, F. G. Schröder, L. Schumacher, G. Schwefer, S. Sclafani, D. Seckel, M. Seikh, S. Seunarine, R. Shah, S. Shefali, N. Shimizu, M. Silva, B. Skrzypek, B. Smithers, R. Snihur, J. Soedingrekso, A. Søgaard, D. Soldin, P. Soldin, G. Sommani, C. Spannfellner, G. M. Spiczak, C. Spiering, M. Stamatikos, T. Stanev, T. Stezelberger, T. Stürwald, T. Stuttard, G. W. Sullivan, I. Taboada, S. Ter-Antonyan, M. Thiesmeyer, W. G. Thompson, J. Thwaites, S. Tilav, K. Tollefson, C. Tönnis, S. Toscano, D. Tosi, A. Trettin, C. F. Tung, R. Turcotte, J. P. Twagirayezu, M. A. Unland Elorrieta, A. K. Upadhyay, K. Upshaw, A. Vaidyanathan, N. Valtonen-Mattila, J. Vandenbroucke, N. van Eijndhoven, D. Vannerom, J. van Santen, J. Vara, J. Veitch-Michaelis, M. Venugopal, M. Vereecken, S. Verpoest, D. Veske, A. Vijai, C. Walck, C. Weaver, P. Weigel, A. Weindl, J. Weldert, A. Y. Wen, C. Wendt, J. Werthebach, M. Weyrauch, N. Whitehorn, C. H. Wiebusch, D. R. Williams, L. Witthaus, A. Wolf, M. Wolf, G. Wrede, X. W. Xu, J. P. Yanez, E. Yildizci, S. Yoshida, R. Young, S. Yu, T. Yuan, Z. Zhang, P. Zhelnin, P. Zilberman, M. Zimmerman, and IceCube Collaboration
- Subjects
High energy astrophysics ,Active galactic nuclei ,Neutrino astronomy ,Transient sources ,Blazars ,Astrophysics ,QB460-466 - Abstract
IceCube alert events are neutrinos with a moderate-to-high probability of having astrophysical origin. In this study, we analyze 11 yr of IceCube data and investigate 122 alert events and a selection of high-energy tracks detected between 2009 and the end of 2021. This high-energy event selection (alert events + high-energy tracks) has an average probability of ≥0.5 of being of astrophysical origin. We search for additional continuous and transient neutrino emission within the high-energy events’ error regions. We find no evidence for significant continuous neutrino emission from any of the alert event directions. The only locally significant neutrino emission is the transient emission associated with the blazar TXS 0506+056, with a local significance of 3 σ , which confirms previous IceCube studies. When correcting for 122 test positions, the global p -value is 0.156 and compatible with the background hypothesis. We constrain the total continuous flux emitted from all 122 test positions at 100 TeV to be below 1.2 × 10 ^−15 (TeV cm ^2 s) ^−1 at 90% confidence assuming an E ^−2 spectrum. This corresponds to 4.5% of IceCube’s astrophysical diffuse flux. Overall, we find no indication that alert events in general are linked to lower-energetic continuous or transient neutrino emission.
- Published
- 2024
- Full Text
- View/download PDF
7. All-sky Search for Transient Astrophysical Neutrino Emission with 10 Years of IceCube Cascade Events
- Author
-
R. Abbasi, M. Ackermann, J. Adams, S. K. Agarwalla, J. A. Aguilar, M. Ahlers, J. M. Alameddine, N. M. Amin, K. Andeen, G. Anton, C. Argüelles, Y. Ashida, S. Athanasiadou, L. Ausborm, S. N. Axani, X. Bai, A. Balagopal V., M. Baricevic, S. W. Barwick, V. Basu, R. Bay, J. J. Beatty, J. Becker Tjus, J. Beise, C. Bellenghi, C. Benning, S. BenZvi, D. Berley, E. Bernardini, D. Z. Besson, E. Blaufuss, S. Blot, F. Bontempo, J. Y. Book, C. Boscolo Meneguolo, S. Böser, O. Botner, J. Böttcher, J. Braun, B. Brinson, J. Brostean-Kaiser, L. Brusa, R. T. Burley, R. S. Busse, D. Butterfield, M. A. Campana, K. Carloni, E. G. Carnie-Bronca, S. Chattopadhyay, N. Chau, C. Chen, Z. Chen, D. Chirkin, S. Choi, B. A. Clark, A. Coleman, G. H. Collin, A. Connolly, J. M. Conrad, P. Coppin, P. Correa, D. F. Cowen, P. Dave, C. De Clercq, J. J. DeLaunay, D. Delgado, S. Deng, K. Deoskar, A. Desai, P. Desiati, K. D. de Vries, G. de Wasseige, T. DeYoung, A. Diaz, J. C. Díaz-Vélez, M. Dittmer, A. Domi, H. Dujmovic, M. A. DuVernois, T. Ehrhardt, A. Eimer, P. Eller, E. Ellinger, S. El Mentawi, D. Elsässer, R. Engel, H. Erpenbeck, J. Evans, P. A. Evenson, K. L. Fan, K. Fang, K. Farrag, A. R. Fazely, A. Fedynitch, N. Feigl, S. Fiedlschuster, C. Finley, L. Fischer, D. Fox, A. Franckowiak, P. Fürst, J. Gallagher, E. Ganster, A. Garcia, L. Gerhardt, A. Ghadimi, C. Glaser, T. Glauch, T. Glüsenkamp, J. G. Gonzalez, D. Grant, S. J. Gray, O. Gries, S. Griffin, S. Griswold, K. M. Groth, C. Günther, P. Gutjahr, C. Ha, C. Haack, A. Hallgren, R. Halliday, L. Halve, F. Halzen, H. Hamdaoui, M. Ha Minh, M. Handt, K. Hanson, J. Hardin, A. A. Harnisch, P. Hatch, A. Haungs, J. Häußler, K. Helbing, J. Hellrung, J. Hermannsgabner, L. Heuermann, N. Heyer, S. Hickford, A. Hidvegi, C. Hill, G. C. Hill, K. D. Hoffman, S. Hori, K. Hoshina, W. Hou, T. Huber, K. Hultqvist, M. Hünnefeld, R. Hussain, K. Hymon, S. In, A. Ishihara, M. Jacquart, O. Janik, M. Jansson, G. S. Japaridze, M. Jeong, M. Jin, B. J. P. Jones, N. Kamp, D. Kang, W. Kang, X. Kang, A. Kappes, D. Kappesser, L. Kardum, T. Karg, M. Karl, A. Karle, A. Katil, U. Katz, M. Kauer, J. L. Kelley, A. Khatee Zathul, A. Kheirandish, J. Kiryluk, S. R. Klein, A. Kochocki, R. Koirala, H. Kolanoski, T. Kontrimas, L. Köpke, C. Kopper, D. J. Koskinen, P. Koundal, M. Kovacevich, M. Kowalski, T. Kozynets, J. Krishnamoorthi, K. Kruiswijk, E. Krupczak, A. Kumar, E. Kun, N. Kurahashi, N. Lad, C. Lagunas Gualda, M. Lamoureux, M. J. Larson, S. Latseva, F. Lauber, J. P. Lazar, J. W. Lee, K. Leonard DeHolton, A. Leszczyńska, M. Lincetto, Y. Liu, M. Liubarska, E. Lohfink, C. Love, C. J. Lozano Mariscal, L. Lu, F. Lucarelli, W. Luszczak, Y. Lyu, J. Madsen, E. Magnus, K. B. M. Mahn, Y. Makino, E. Manao, S. Mancina, W. Marie Sainte, I. C. Mariş, S. Marka, Z. Marka, M. Marsee, I. Martinez-Soler, R. Maruyama, F. Mayhew, T. McElroy, F. McNally, J. V. Mead, K. Meagher, S. Mechbal, A. Medina, M. Meier, Y. Merckx, L. Merten, J. Micallef, J. Mitchell, T. Montaruli, R. W. Moore, Y. Morii, R. Morse, M. Moulai, T. Mukherjee, R. Naab, R. Nagai, M. Nakos, U. Naumann, J. Necker, A. Negi, M. Neumann, H. Niederhausen, M. U. Nisa, A. Noell, A. Novikov, S. C. Nowicki, A. Obertacke Pollmann, V. O’Dell, B. Oeyen, A. Olivas, R. Orsoe, J. Osborn, E. O’Sullivan, H. Pandya, N. Park, G. K. Parker, E. N. Paudel, L. Paul, C. Pérez de los Heros, J. Peterson, S. Philippen, A. Pizzuto, M. Plum, A. Pontén, Y. Popovych, M. Prado Rodriguez, B. Pries, R. Procter-Murphy, G. T. Przybylski, C. Raab, J. Rack-Helleis, K. Rawlins, Z. Rechav, A. Rehman, P. Reichherzer, E. Resconi, S. Reusch, W. Rhode, B. Riedel, A. Rifaie, E. J. Roberts, S. Robertson, S. Rodan, G. Roellinghoff, M. Rongen, A. Rosted, C. Rott, T. Ruhe, L. Ruohan, D. Ryckbosch, I. Safa, J. Saffer, D. Salazar-Gallegos, P. Sampathkumar, S. E. Sanchez Herrera, A. Sandrock, M. Santander, S. Sarkar, J. Savelberg, P. Savina, M. Schaufel, H. Schieler, S. Schindler, L. Schlickmann, B. Schlüter, F. Schlüter, N. Schmeisser, T. Schmidt, J. Schneider, F. G. Schröder, L. Schumacher, S. Sclafani, D. Seckel, M. Seikh, S. Seunarine, R. Shah, S. Shefali, N. Shimizu, M. Silva, B. Skrzypek, B. Smithers, R. Snihur, J. Soedingrekso, A. Søgaard, D. Soldin, P. Soldin, G. Sommani, C. Spannfellner, G. M. Spiczak, C. Spiering, M. Stamatikos, T. Stanev, T. Stezelberger, T. Stürwald, T. Stuttard, G. W. Sullivan, I. Taboada, S. Ter-Antonyan, M. Thiesmeyer, W. G. Thompson, J. Thwaites, S. Tilav, K. Tollefson, C. Tönnis, S. Toscano, D. Tosi, A. Trettin, C. F. Tung, R. Turcotte, J. P. Twagirayezu, M. A. Unland Elorrieta, A. K. Upadhyay, K. Upshaw, A. Vaidyanathan, N. Valtonen-Mattila, J. Vandenbroucke, N. van Eijndhoven, D. Vannerom, J. van Santen, J. Vara, J. Veitch-Michaelis, M. Venugopal, M. Vereecken, S. Verpoest, D. Veske, A. Vijai, C. Walck, Y. Wang, C. Weaver, P. Weigel, A. Weindl, J. Weldert, A. Y. Wen, C. Wendt, J. Werthebach, M. Weyrauch, N. Whitehorn, C. H. Wiebusch, D. R. Williams, L. Witthaus, A. Wolf, M. Wolf, G. Wrede, X. W. Xu, J. P. Yanez, E. Yildizci, S. Yoshida, R. Young, S. Yu, T. Yuan, Z. Zhang, P. Zhelnin, P. Zilberman, M. Zimmerman, and IceCube Collaboration
- Subjects
Neutrino astronomy ,High energy astrophysics ,Transient sources ,Astrophysics ,QB460-466 - Abstract
Neutrino flares in the sky are searched for in data collected by IceCube between 2011 and 2021 May. This data set contains cascade-like events originating from charged-current electron neutrino and tau neutrino interactions and all-flavor neutral-current interactions. IceCube’s previous all-sky searches for neutrino flares used data sets consisting of track-like events originating from charged-current muon neutrino interactions. The cascade data set is statistically independent of the track data sets, and while inferior in angular resolution, the low-background nature makes it competitive and complementary to previous searches. No statistically significant flare of neutrino emission was observed in an all-sky scan. Upper limits are calculated on neutrino flares of varying duration from 1 hr to 100 days. Furthermore, constraints on the contribution of these flares to the diffuse astrophysical neutrino flux are presented, showing that multiple unresolved transient sources may contribute to the diffuse astrophysical neutrino flux.
- Published
- 2024
- Full Text
- View/download PDF
8. Search for 10–1000 GeV Neutrinos from Gamma-Ray Bursts with IceCube
- Author
-
R. Abbasi, M. Ackermann, J. Adams, S. K. Agarwalla, J. A. Aguilar, M. Ahlers, J. M. Alameddine, N. M. Amin, K. Andeen, G. Anton, C. Argüelles, Y. Ashida, S. Athanasiadou, L. Ausborm, S. N. Axani, X. Bai, A. Balagopal V., M. Baricevic, S. W. Barwick, V. Basu, R. Bay, J. J. Beatty, J. Becker Tjus, J. Beise, C. Bellenghi, C. Benning, S. BenZvi, D. Berley, E. Bernardini, D. Z. Besson, E. Blaufuss, S. Blot, F. Bontempo, J. Y. Book, C. Boscolo Meneguolo, S. Böser, O. Botner, J. Böttcher, J. Braun, B. Brinson, J. Brostean-Kaiser, L. Brusa, R. T. Burley, R. S. Busse, D. Butterfield, M. A. Campana, K. Carloni, E. G. Carnie-Bronca, S. Chattopadhyay, N. Chau, C. Chen, Z. Chen, D. Chirkin, S. Choi, B. A. Clark, A. Coleman, G. H. Collin, A. Connolly, J. M. Conrad, P. Coppin, P. Correa, D. F. Cowen, P. Dave, C. De Clercq, J. J. DeLaunay, D. Delgado, S. Deng, K. Deoskar, A. Desai, P. Desiati, K. D. de Vries, G. de Wasseige, T. DeYoung, A. Diaz, J. C. Díaz-Vélez, M. Dittmer, A. Domi, H. Dujmovic, M. A. DuVernois, T. Ehrhardt, A. Eimer, P. Eller, E. Ellinger, S. El Mentawi, D. Elsässer, R. Engel, H. Erpenbeck, J. Evans, P. A. Evenson, K. L. Fan, K. Fang, K. Farrag, A. R. Fazely, A. Fedynitch, N. Feigl, S. Fiedlschuster, C. Finley, L. Fischer, D. Fox, A. Franckowiak, P. Fürst, J. Gallagher, E. Ganster, A. Garcia, L. Gerhardt, A. Ghadimi, C. Glaser, T. Glauch, T. Glüsenkamp, J. G. Gonzalez, D. Grant, S. J. Gray, O. Gries, S. Griffin, S. Griswold, K. M. Groth, C. Günther, P. Gutjahr, C. Ha, C. Haack, A. Hallgren, R. Halliday, L. Halve, F. Halzen, H. Hamdaoui, M. Ha Minh, M. Handt, K. Hanson, J. Hardin, A. A. Harnisch, P. Hatch, A. Haungs, J. Häußler, K. Helbing, J. Hellrung, J. Hermannsgabner, L. Heuermann, N. Heyer, S. Hickford, A. Hidvegi, C. Hill, G. C. Hill, K. D. Hoffman, S. Hori, K. Hoshina, W. Hou, T. Huber, K. Hultqvist, M. Hünnefeld, R. Hussain, K. Hymon, S. In, A. Ishihara, M. Jacquart, O. Janik, M. Jansson, G. S. Japaridze, M. Jeong, M. Jin, B. J. P. Jones, N. Kamp, D. Kang, W. Kang, X. Kang, A. Kappes, D. Kappesser, L. Kardum, T. Karg, M. Karl, A. Karle, A. Katil, U. Katz, M. Kauer, J. L. Kelley, A. Khatee Zathul, A. Kheirandish, J. Kiryluk, S. R. Klein, A. Kochocki, R. Koirala, H. Kolanoski, T. Kontrimas, L. Köpke, C. Kopper, D. J. Koskinen, P. Koundal, M. Kovacevich, M. Kowalski, T. Kozynets, J. Krishnamoorthi, K. Kruiswijk, E. Krupczak, A. Kumar, E. Kun, N. Kurahashi, N. Lad, C. Lagunas Gualda, M. Lamoureux, M. J. Larson, S. Latseva, F. Lauber, J. P. Lazar, J. W. Lee, K. Leonard DeHolton, A. Leszczyńska, M. Lincetto, Y. Liu, M. Liubarska, E. Lohfink, C. Love, C. J. Lozano Mariscal, L. Lu, F. Lucarelli, W. Luszczak, Y. Lyu, J. Madsen, E. Magnus, K. B. M. Mahn, Y. Makino, E. Manao, S. Mancina, W. Marie Sainte, I. C. Mariş, S. Marka, Z. Marka, M. Marsee, I. Martinez-Soler, R. Maruyama, F. Mayhew, T. McElroy, F. McNally, J. V. Mead, K. Meagher, S. Mechbal, A. Medina, M. Meier, Y. Merckx, L. Merten, J. Micallef, J. Mitchell, T. Montaruli, R. W. Moore, Y. Morii, R. Morse, M. Moulai, T. Mukherjee, R. Naab, R. Nagai, M. Nakos, U. Naumann, J. Necker, A. Negi, M. Neumann, H. Niederhausen, M. U. Nisa, A. Noell, A. Novikov, S. C. Nowicki, A. Obertacke Pollmann, V. O’Dell, B. Oeyen, A. Olivas, R. Orsoe, J. Osborn, E. O’Sullivan, H. Pandya, N. Park, G. K. Parker, E. N. Paudel, L. Paul, C. Pérez de los Heros, J. Peterson, S. Philippen, A. Pizzuto, M. Plum, A. Pontén, Y. Popovych, M. Prado Rodriguez, B. Pries, R. Procter-Murphy, G. T. Przybylski, C. Raab, J. Rack-Helleis, K. Rawlins, Z. Rechav, A. Rehman, P. Reichherzer, E. Resconi, S. Reusch, W. Rhode, B. Riedel, A. Rifaie, E. J. Roberts, S. Robertson, S. Rodan, G. Roellinghoff, M. Rongen, A. Rosted, C. Rott, T. Ruhe, L. Ruohan, D. Ryckbosch, I. Safa, J. Saffer, D. Salazar-Gallegos, P. Sampathkumar, S. E. Sanchez Herrera, A. Sandrock, M. Santander, S. Sarkar, J. Savelberg, P. Savina, M. Schaufel, H. Schieler, S. Schindler, L. Schlickmann, B. Schlüter, F. Schlüter, N. Schmeisser, T. Schmidt, J. Schneider, F. G. Schröder, L. Schumacher, S. Sclafani, D. Seckel, M. Seikh, S. Seunarine, R. Shah, S. Shefali, N. Shimizu, C. Silva, M. Silva, B. Skrzypek, B. Smithers, R. Snihur, J. Soedingrekso, A. Søgaard, D. Soldin, P. Soldin, G. Sommani, C. Spannfellner, G. M. Spiczak, C. Spiering, M. Stamatikos, T. Stanev, T. Stezelberger, T. Stürwald, T. Stuttard, G. W. Sullivan, I. Taboada, S. Ter-Antonyan, M. Thiesmeyer, W. G. Thompson, J. Thwaites, S. Tilav, K. Tollefson, C. Tönnis, S. Toscano, D. Tosi, A. Trettin, C. F. Tung, R. Turcotte, J. P. Twagirayezu, M. A. Unland Elorrieta, A. K. Upadhyay, K. Upshaw, A. Vaidyanathan, N. Valtonen-Mattila, J. Vandenbroucke, N. van Eijndhoven, D. Vannerom, J. van Santen, J. Vara, J. Veitch-Michaelis, M. Venugopal, M. Vereecken, S. Verpoest, D. Veske, A. Vijai, C. Walck, Y. Wang, C. Weaver, P. Weigel, A. Weindl, J. Weldert, A. Y. Wen, C. Wendt, J. Werthebach, M. Weyrauch, N. Whitehorn, C. H. Wiebusch, D. R. Williams, L. Witthaus, A. Wolf, M. Wolf, G. Wrede, X. W. Xu, J. P. Yanez, E. Yildizci, S. Yoshida, R. Young, S. Yu, T. Yuan, Z. Zhang, P. Zhelnin, P. Zilberman, M. Zimmerman, and IceCube Collaboration
- Subjects
Cosmological neutrinos ,Gamma-ray bursts ,Astrophysics ,QB460-466 - Abstract
We present the results of a search for 10–1000 GeV neutrinos from 2268 gamma-ray bursts (GRBs) over 8 yr of IceCube-DeepCore data. This work probes burst physics below the photosphere where electromagnetic radiation cannot escape. Neutrinos of tens of giga electronvolts are predicted in sub-photospheric collision of free-streaming neutrons with bulk-jet protons. In a first analysis, we searched for the most significant neutrino-GRB coincidence using six overlapping time windows centered on the prompt phase of each GRB. In a second analysis, we conducted a search for a group of GRBs, each individually too weak to be detectable, but potentially significant when combined. No evidence of neutrino emission is found for either analysis. The most significant neutrino coincidence is for Fermi-GBM GRB bn 140807500, with a p -value of 0.097 corrected for all trials. The binomial test used to search for a group of GRBs had a p -value of 0.65 after all trial corrections. The binomial test found a group consisting only of GRB bn 140807500 and no additional GRBs. The neutrino limits of this work complement those obtained by IceCube at tera electronvolt to peta electronvolt energies. We compare our findings for the large set of GRBs as well as GRB 221009A to the sub-photospheric neutron-proton collision model and find that GRB 221009A provides the most constraining limit on baryon loading. For a jet Lorentz factor of 300 (800), the baryon loading on GRB 221009A is lower than 3.85 (2.13) at a 90% confidence level.
- Published
- 2024
- Full Text
- View/download PDF
9. Erratum: 'Search for 10–1000 GeV Neutrinos from Gamma-Ray Bursts with IceCube' (2024, ApJ, 964, 126)
- Author
-
R. Abbasi, M. Ackermann, J. Adams, S. K. Agarwalla, J. A. Aguilar, M. Ahlers, J. M. Alameddine, N. M. Amin, K. Andeen, G. Anton, C. Argüelles, Y. Ashida, S. Athanasiadou, L. Ausborm, S. N. Axani, X. Bai, A. Balagopal V., M. Baricevic, S. W. Barwick, V. Basu, R. Bay, J. J. Beatty, J. Becker Tjus, J. Beise, C. Bellenghi, C. Benning, S. BenZvi, D. Berley, E. Bernardini, D. Z. Besson, E. Blaufuss, S. Blot, F. Bontempo, J. Y. Book, C. Boscolo Meneguolo, S. Böser, O. Botner, J. Böttcher, J. Braun, B. Brinson, J. Brostean-Kaiser, L. Brusa, R. T. Burley, R. S. Busse, D. Butterfield, M. A. Campana, K. Carloni, E. G. Carnie-Bronca, S. Chattopadhyay, N. Chau, C. Chen, Z. Chen, D. Chirkin, S. Choi, B. A. Clark, A. Coleman, G. H. Collin, A. Connolly, J. M. Conrad, P. Coppin, P. Correa, D. F. Cowen, P. Dave, C. De Clercq, J. J. DeLaunay, D. Delgado, S. Deng, K. Deoskar, A. Desai, P. Desiati, K. D. de Vries, G. de Wasseige, T. DeYoung, A. Diaz, J. C. Díaz-Vélez, M. Dittmer, A. Domi, H. Dujmovic, M. A. DuVernois, T. Ehrhardt, A. Eimer, P. Eller, E. Ellinger, S. El Mentawi, D. Elsässer, R. Engel, H. Erpenbeck, J. Evans, P. A. Evenson, K. L. Fan, K. Fang, K. Farrag, A. R. Fazely, A. Fedynitch, N. Feigl, S. Fiedlschuster, C. Finley, L. Fischer, D. Fox, A. Franckowiak, P. Fürst, J. Gallagher, E. Ganster, A. Garcia, L. Gerhardt, A. Ghadimi, C. Glaser, T. Glauch, T. Glüsenkamp, J. G. Gonzalez, D. Grant, S. J. Gray, O. Gries, S. Griffin, S. Griswold, K. M. Groth, C. Günther, P. Gutjahr, C. Ha, C. Haack, A. Hallgren, R. Halliday, L. Halve, F. Halzen, H. Hamdaoui, M. Ha Minh, M. Handt, K. Hanson, J. Hardin, A. A. Harnisch, P. Hatch, A. Haungs, J. Häußler, K. Helbing, J. Hellrung, J. Hermannsgabner, L. Heuermann, N. Heyer, S. Hickford, A. Hidvegi, C. Hill, G. C. Hill, K. D. Hoffman, S. Hori, K. Hoshina, W. Hou, T. Huber, K. Hultqvist, M. Hünnefeld, R. Hussain, K. Hymon, S. In, A. Ishihara, M. Jacquart, O. Janik, M. Jansson, G. S. Japaridze, M. Jeong, M. Jin, B. J. P. Jones, N. Kamp, D. Kang, W. Kang, X. Kang, A. Kappes, D. Kappesser, L. Kardum, T. Karg, M. Karl, A. Karle, A. Katil, U. Katz, M. Kauer, J. L. Kelley, A. Khatee Zathul, A. Kheirandish, J. Kiryluk, S. R. Klein, A. Kochocki, R. Koirala, H. Kolanoski, T. Kontrimas, L. Köpke, C. Kopper, D. J. Koskinen, P. Koundal, M. Kovacevich, M. Kowalski, T. Kozynets, J. Krishnamoorthi, K. Kruiswijk, E. Krupczak, A. Kumar, E. Kun, N. Kurahashi, N. Lad, C. Lagunas Gualda, M. Lamoureux, M. J. Larson, S. Latseva, F. Lauber, J. P. Lazar, J. W. Lee, K. Leonard DeHolton, A. Leszczyńska, M. Lincetto, Y. Liu, M. Liubarska, E. Lohfink, C. Love, C. J. Lozano Mariscal, L. Lu, F. Lucarelli, W. Luszczak, Y. Lyu, J. Madsen, E. Magnus, K. B. M. Mahn, Y. Makino, E. Manao, S. Mancina, W. Marie Sainte, I. C. Mariş, S. Marka, Z. Marka, M. Marsee, I. Martinez-Soler, R. Maruyama, F. Mayhew, T. McElroy, F. McNally, J. V. Mead, K. Meagher, S. Mechbal, A. Medina, M. Meier, Y. Merckx, L. Merten, J. Micallef, J. Mitchell, T. Montaruli, R. W. Moore, Y. Morii, R. Morse, M. Moulai, T. Mukherjee, R. Naab, R. Nagai, M. Nakos, U. Naumann, J. Necker, A. Negi, M. Neumann, H. Niederhausen, M. U. Nisa, A. Noell, A. Novikov, S. C. Nowicki, A. Obertacke Pollmann, V. O’Dell, B. Oeyen, A. Olivas, R. Orsoe, J. Osborn, E. O’Sullivan, H. Pandya, N. Park, G. K. Parker, E. N. Paudel, L. Paul, C. Pérez de los Heros, J. Peterson, S. Philippen, A. Pizzuto, M. Plum, A. Pontén, Y. Popovych, M. Prado Rodriguez, B. Pries, R. Procter-Murphy, G. T. Przybylski, C. Raab, J. Rack-Helleis, K. Rawlins, Z. Rechav, A. Rehman, P. Reichherzer, E. Resconi, S. Reusch, W. Rhode, B. Riedel, A. Rifaie, E. J. Roberts, S. Robertson, S. Rodan, G. Roellinghoff, M. Rongen, A. Rosted, C. Rott, T. Ruhe, L. Ruohan, D. Ryckbosch, I. Safa, J. Saffer, D. Salazar-Gallegos, P. Sampathkumar, S. E. Sanchez Herrera, A. Sandrock, M. Santander, S. Sarkar, J. Savelberg, P. Savina, M. Schaufel, H. Schieler, S. Schindler, L. Schlickmann, B. Schlüter, F. Schlüter, N. Schmeisser, T. Schmidt, J. Schneider, F. G. Schröder, L. Schumacher, S. Sclafani, D. Seckel, M. Seikh, S. Seunarine, R. Shah, S. Shefali, N. Shimizu, C. Silva, M. Silva, B. Skrzypek, B. Smithers, R. Snihur, J. Soedingrekso, A. Søgaard, D. Soldin, P. Soldin, G. Sommani, C. Spannfellner, G. M. Spiczak, C. Spiering, M. Stamatikos, T. Stanev, T. Stezelberger, T. Stürwald, T. Stuttard, G. W. Sullivan, I. Taboada, S. Ter-Antonyan, M. Thiesmeyer, W. G. Thompson, J. Thwaites, S. Tilav, K. Tollefson, C. Tönnis, S. Toscano, D. Tosi, A. Trettin, C. F. Tung, R. Turcotte, J. P. Twagirayezu, M. A. Unland Elorrieta, A. K. Upadhyay, K. Upshaw, A. Vaidyanathan, N. Valtonen-Mattila, J. Vandenbroucke, N. van Eijndhoven, D. Vannerom, J. van Santen, J. Vara, J. Veitch-Michaelis, M. Venugopal, M. Vereecken, S. Verpoest, D. Veske, A. Vijai, C. Walck, Y. Wang, C. Weaver, P. Weigel, A. Weindl, J. Weldert, A. Y. Wen, C. Wendt, J. Werthebach, M. Weyrauch, N. Whitehorn, C. H. Wiebusch, D. R. Williams, L. Witthaus, A. Wolf, M. Wolf, G. Wrede, X. W. Xu, J. P. Yanez, E. Yildizci, S. Yoshida, R. Young, S. Yu, T. Yuan, Z. Zhang, P. Zhelnin, P. Zilberman, M. Zimmerman, and IceCube Collaboration
- Subjects
Astrophysics ,QB460-466 - Published
- 2024
- Full Text
- View/download PDF
10. Probing the Connection between IceCube Neutrinos and MOJAVE AGN
- Author
-
R. Abbasi, M. Ackermann, J. Adams, S. K. Agarwalla, J. A. Aguilar, M. Ahlers, J. M. Alameddine, N. M. Amin, K. Andeen, C. Argüelles, Y. Ashida, S. Athanasiadou, L. Ausborm, S. N. Axani, X. Bai, A. Balagopal V., M. Baricevic, S. W. Barwick, S. Bash, V. Basu, R. Bay, J. J. Beatty, J. Becker Tjus, J. Beise, C. Bellenghi, C. Benning, S. BenZvi, D. Berley, E. Bernardini, D. Z. Besson, E. Blaufuss, L. Bloom, S. Blot, F. Bontempo, J. Y. Book Motzkin, C. Boscolo Meneguolo, S. Böser, O. Botner, J. Böttcher, J. Braun, B. Brinson, J. Brostean-Kaiser, L. Brusa, R. T. Burley, D. Butterfield, M. A. Campana, I. Caracas, K. Carloni, J. Carpio, S. Chattopadhyay, N. Chau, Z. Chen, D. Chirkin, S. Choi, B. A. Clark, A. Coleman, G. H. Collin, A. Connolly, J. M. Conrad, R. Corley, D. F. Cowen, P. Dave, C. De Clercq, J. J. DeLaunay, D. Delgado, S. Deng, A. Desai, P. Desiati, K. D. de Vries, G. de Wasseige, T. DeYoung, A. Diaz, J. C. Díaz-Vélez, P. Dierichs, M. Dittmer, A. Domi, L. Draper, H. Dujmovic, D. Durnford, K. Dutta, M. A. DuVernois, T. Ehrhardt, L. Eidenschink, A. Eimer, P. Eller, E. Ellinger, S. El Mentawi, D. Elsässer, R. Engel, H. Erpenbeck, J. Evans, P. A. Evenson, K. L. Fan, K. Fang, K. Farrag, A. R. Fazely, A. Fedynitch, N. Feigl, S. Fiedlschuster, C. Finley, L. Fischer, D. Fox, A. Franckowiak, S. Fukami, P. Fürst, J. Gallagher, E. Ganster, A. Garcia, M. Garcia, G. Garg, E. Genton, L. Gerhardt, A. Ghadimi, C. Girard-Carillo, C. Glaser, T. Glüsenkamp, J. G. Gonzalez, S. Goswami, A. Granados, D. Grant, S. J. Gray, O. Gries, S. Griffin, S. Griswold, K. M. Groth, D. Guevel, C. Günther, P. Gutjahr, C. Ha, C. Haack, A. Hallgren, L. Halve, F. Halzen, H. Hamdaoui, M. Ha Minh, M. Handt, K. Hanson, J. Hardin, A. A. Harnisch, P. Hatch, A. Haungs, J. Häußler, K. Helbing, J. Hellrung, J. Hermannsgabner, L. Heuermann, N. Heyer, S. Hickford, A. Hidvegi, C. Hill, G. C. Hill, K. D. Hoffman, S. Hori, K. Hoshina, M. Hostert, W. Hou, T. Huber, K. Hultqvist, M. Hünnefeld, R. Hussain, K. Hymon, A. Ishihara, W. Iwakiri, M. Jacquart, S. Jain, O. Janik, M. Jansson, G. S. Japaridze, M. Jeong, M. Jin, B. J. P. Jones, N. Kamp, D. Kang, W. Kang, X. Kang, A. Kappes, D. Kappesser, L. Kardum, T. Karg, M. Karl, A. Karle, A. Katil, U. Katz, M. Kauer, J. L. Kelley, M. Khanal, A. Khatee Zathul, A. Kheirandish, J. Kiryluk, S. R. Klein, A. Kochocki, R. Koirala, H. Kolanoski, T. Kontrimas, L. Köpke, C. Kopper, D. J. Koskinen, P. Koundal, M. Kovacevich, M. Kowalski, T. Kozynets, J. Krishnamoorthi, K. Kruiswijk, E. Krupczak, A. Kumar, E. Kun, N. Kurahashi, N. Lad, C. Lagunas Gualda, M. Lamoureux, M. J. Larson, S. Latseva, F. Lauber, J. P. Lazar, J. W. Lee, K. Leonard DeHolton, A. Leszczyńska, J. Liao, M. Lincetto, Y. T. Liu, M. Liubarska, C. Love, L. Lu, F. Lucarelli, W. Luszczak, Y. Lyu, J. Madsen, E. Magnus, K. B. M. Mahn, Y. Makino, E. Manao, S. Mancina, W. Marie Sainte, I. C. Mariş, S. Marka, Z. Marka, M. Marsee, I. Martinez-Soler, R. Maruyama, F. Mayhew, F. McNally, J. V. Mead, K. Meagher, S. Mechbal, A. Medina, M. Meier, Y. Merckx, L. Merten, J. Micallef, J. Mitchell, T. Montaruli, R. W. Moore, Y. Morii, R. Morse, M. Moulai, T. Mukherjee, R. Naab, R. Nagai, M. Nakos, U. Naumann, J. Necker, A. Negi, L. Neste, M. Neumann, H. Niederhausen, M. U. Nisa, K. Noda, A. Noell, A. Novikov, A. Obertacke Pollmann, V. O’Dell, B. Oeyen, A. Olivas, R. Orsoe, J. Osborn, E. O’Sullivan, V. Palusova, H. Pandya, N. Park, G. K. Parker, E. N. Paudel, L. Paul, C. Pérez de los Heros, T. Pernice, J. Peterson, A. Pizzuto, M. Plum, A. Pontén, Y. Popovych, M. Prado Rodriguez, B. Pries, R. Procter-Murphy, G. T. Przybylski, C. Raab, J. Rack-Helleis, M. Ravn, K. Rawlins, Z. Rechav, A. Rehman, P. Reichherzer, E. Resconi, S. Reusch, W. Rhode, B. Riedel, A. Rifaie, E. J. Roberts, S. Robertson, S. Rodan, G. Roellinghoff, M. Rongen, A. Rosted, C. Rott, T. Ruhe, L. Ruohan, D. Ryckbosch, I. Safa, J. Saffer, D. Salazar-Gallegos, P. Sampathkumar, A. Sandrock, M. Santander, S. Sarkar, J. Savelberg, P. Savina, P. Schaile, M. Schaufel, H. Schieler, S. Schindler, L. Schlickmann, B. Schlüter, F. Schlüter, N. Schmeisser, T. Schmidt, J. Schneider, F. G. Schröder, L. Schumacher, S. Sclafani, D. Seckel, M. Seikh, M. Seo, S. Seunarine, P. Sevle Myhr, R. Shah, S. Shefali, N. Shimizu, M. Silva, B. Skrzypek, B. Smithers, R. Snihur, J. Soedingrekso, A. Søgaard, D. Soldin, P. Soldin, G. Sommani, C. Spannfellner, G. M. Spiczak, C. Spiering, M. Stamatikos, T. Stanev, T. Stezelberger, T. Stürwald, T. Stuttard, G. W. Sullivan, I. Taboada, S. Ter-Antonyan, A. Terliuk, M. Thiesmeyer, W. G. Thompson, J. Thwaites, S. Tilav, K. Tollefson, C. Tönnis, S. Toscano, D. Tosi, A. Trettin, R. Turcotte, J. P. Twagirayezu, M. A. Unland Elorrieta, A. K. Upadhyay, K. Upshaw, A. Vaidyanathan, N. Valtonen-Mattila, J. Vandenbroucke, N. van Eijndhoven, D. Vannerom, J. van Santen, J. Vara, F. Varsi, J. Veitch-Michaelis, M. Venugopal, M. Vereecken, S. Vergara Carrasco, S. Verpoest, D. Veske, A. Vijai, C. Walck, A. Wang, C. Weaver, P. Weigel, A. Weindl, J. Weldert, A. Y. Wen, C. Wendt, J. Werthebach, M. Weyrauch, N. Whitehorn, C. H. Wiebusch, D. R. Williams, L. Witthaus, A. Wolf, M. Wolf, G. Wrede, X. W. Xu, J. P. Yanez, E. Yildizci, S. Yoshida, R. Young, S. Yu, T. Yuan, Z. Zhang, P. Zhelnin, P. Zilberman, and M. Zimmerman
- Subjects
Neutrino astronomy ,High energy astrophysics ,Radio astronomy ,Astrophysics ,QB460-466 - Abstract
Active galactic nuclei (AGN) are prime candidate sources of the high-energy, astrophysical neutrinos detected by IceCube. This is demonstrated by the real-time multimessenger detection of the blazar TXS 0506+056 and the recent evidence of neutrino emission from NGC 1068 from a separate time-averaged study. However, the production mechanism of the astrophysical neutrinos in AGN is not well established, which can be resolved via correlation studies with photon observations. For neutrinos produced due to photohadronic interactions in AGN, in addition to a correlation of neutrinos with high-energy photons, there would also be a correlation of neutrinos with photons emitted at radio wavelengths. In this work, we perform an in-depth stacking study of the correlation between 15 GHz radio observations of AGN reported in the MOJAVE XV catalog, and 10 yr of neutrino data from IceCube. We also use a time-dependent approach, which improves the statistical power of the stacking analysis. No significant correlation was found for both analyses, and upper limits are reported. When compared to the IceCube diffuse flux, at 100 TeV and for a spectral index of 2.5, the upper limits derived are ∼3% and ∼9% for the time-averaged and time-dependent cases, respectively.
- Published
- 2024
- Full Text
- View/download PDF
11. Search for Joint Multimessenger Signals from Potential Galactic Cosmic-Ray Accelerators with HAWC and IceCube
- Author
-
R. Alfaro, C. Alvarez, J. C. Arteaga-Velázquez, D. Avila Rojas, H. A. Ayala Solares, R. Babu, E. Belmont-Moreno, K. S. Caballero-Mora, T. Capistrán, A. Carramiñana, S. Casanova, U. Cotti, J. Cotzomi, S. Coutiño de León, E. De la Fuente, D. Depaoli, N. Di Lalla, R. Diaz Hernandez, J. C. Díaz-Vélez, K. Engel, T. Ergin, K. L. Fan, K. Fang, N. Fraija, S. Fraija, J. A. García-González, F. Garfias, M. M. González, J. A. Goodman, S. Groetsch, J. P. Harding, S. Hernández-Cadena, I. Herzog, D. Huang, F. Hueyotl-Zahuantitla, P. Hüntemeyer, A. Iriarte, S. Kaufmann, J. Lee, H. León Vargas, G. Luis-Raya, K. Malone, J. Martínez-Castro, J. A. Matthews, P. Miranda-Romagnoli, J. A. Montes, E. Moreno, M. Mostafá, L. Nellen, M. U. Nisa, N. Omodei, M. Osorio, Y. Pérez Araujo, E. G. Pérez-Pérez, C. D. Rho, D. Rosa-González, H. Salazar, D. Salazar-Gallegos, A. Sandoval, M. Schneider, J. Serna-Franco, A. J. Smith, Y. Son, O. Tibolla, K. Tollefson, I. Torres, R. Torres-Escobedo, R. Turner, F. Ureña-Mena, X. Wang, I. J. Watson, K. Whitaker, E. Willox, H. Wu, S. Yu, S. Yun-Cárcamo, H. Zhou, C. de León, HAWC Collaboration, R. Abbasi, M. Ackermann, J. Adams, S. K. Agarwalla, J. A. Aguilar, M. Ahlers, J. M. Alameddine, N. M. Amin, K. Andeen, C. Argüelles, Y. Ashida, S. Athanasiadou, L. Ausborm, S. N. Axani, X. Bai, A. Balagopal V., M. Baricevic, S. W. Barwick, S. Bash, V. Basu, R. Bay, J. J. Beatty, J. Becker Tjus, J. Beise, C. Bellenghi, C. Benning, S. BenZvi, D. Berley, E. Bernardini, D. Z. Besson, E. Blaufuss, L. Bloom, S. Blot, F. Bontempo, J. Y. Book Motzkin, C. Boscolo Meneguolo, S. Böser, O. Botner, J. Böttcher, J. Braun, B. Brinson, J. Brostean-Kaiser, L. Brusa, R. T. Burley, D. Butterfield, M. A. Campana, I. Caracas, K. Carloni, J. Carpio, S. Chattopadhyay, N. Chau, Z. Chen, D. Chirkin, S. Choi, B. A. Clark, A. Coleman, G. H. Collin, A. Connolly, J. M. Conrad, P. Coppin, R. Corley, P. Correa, D. F. Cowen, P. Dave, C. De Clercq, J. J. DeLaunay, D. Delgado, S. Deng, A. Desai, P. Desiati, K. D. de Vries, G. de Wasseige, T. DeYoung, A. Diaz, P. Dierichs, M. Dittmer, A. Domi, L. Draper, H. Dujmovic, K. Dutta, M. A. DuVernois, T. Ehrhardt, L. Eidenschink, A. Eimer, P. Eller, E. Ellinger, S. El Mentawi, D. Elsässer, R. Engel, H. Erpenbeck, J. Evans, P. A. Evenson, K. Farrag, A. R. Fazely, A. Fedynitch, N. Feigl, S. Fiedlschuster, C. Finley, L. Fischer, D. Fox, A. Franckowiak, S. Fukami, P. Fürst, J. Gallagher, E. Ganster, A. Garcia, M. Garcia, G. Garg, E. Genton, L. Gerhardt, A. Ghadimi, C. Girard-Carillo, C. Glaser, T. Glüsenkamp, J. G. Gonzalez, S. Goswami, A. Granados, D. Grant, S. J. Gray, O. Gries, S. Griffin, S. Griswold, K. M. Groth, C. Günther, P. Gutjahr, C. Ha, C. Haack, A. Hallgren, L. Halve, F. Halzen, H. Hamdaoui, M. Ha Minh, M. Handt, K. Hanson, J. Hardin, A. A. Harnisch, P. Hatch, A. Haungs, J. Häußler, K. Helbing, J. Hellrung, J. Hermannsgabner, L. Heuermann, N. Heyer, S. Hickford, A. Hidvegi, C. Hill, G. C. Hill, K. D. Hoffman, S. Hori, K. Hoshina, M. Hostert, W. Hou, T. Huber, K. Hultqvist, M. Hünnefeld, R. Hussain, K. Hymon, A. Ishihara, W. Iwakiri, M. Jacquart, O. Janik, M. Jansson, G. S. Japaridze, M. Jeong, M. Jin, B. J. P. Jones, N. Kamp, D. Kang, W. Kang, X. Kang, A. Kappes, D. Kappesser, L. Kardum, T. Karg, M. Karl, A. Karle, A. Katil, U. Katz, M. Kauer, J. L. Kelley, M. Khanal, A. Khatee Zathul, A. Kheirandish, J. Kiryluk, S. R. Klein, A. Kochocki, R. Koirala, H. Kolanoski, T. Kontrimas, L. Köpke, C. Kopper, D. J. Koskinen, P. Koundal, M. Kovacevich, M. Kowalski, T. Kozynets, J. Krishnamoorthi, K. Kruiswijk, E. Krupczak, A. Kumar, E. Kun, N. Kurahashi, N. Lad, C. Lagunas Gualda, M. Lamoureux, M. J. Larson, S. Latseva, F. Lauber, J. P. Lazar, J. W. Lee, K. Leonard DeHolton, A. Leszczyńska, J. Liao, M. Lincetto, Y. T. Liu, M. Liubarska, E. Lohfink, C. Love, C. J. Lozano Mariscal, L. Lu, F. Lucarelli, W. Luszczak, Y. Lyu, J. Madsen, E. Magnus, K. B. M. Mahn, Y. Makino, E. Manao, S. Mancina, W. Marie Sainte, I. C. Mariş, S. Marka, Z. Marka, M. Marsee, I. Martinez-Soler, R. Maruyama, F. Mayhew, F. McNally, J. V. Mead, K. Meagher, S. Mechbal, A. Medina, M. Meier, Y. Merckx, L. Merten, J. Micallef, J. Mitchell, T. Montaruli, R. W. Moore, Y. Morii, R. Morse, M. Moulai, T. Mukherjee, R. Naab, R. Nagai, M. Nakos, U. Naumann, J. Necker, A. Negi, L. Neste, M. Neumann, H. Niederhausen, K. Noda, A. Noell, A. Novikov, A. Obertacke Pollmann, V. O’Dell, B. Oeyen, A. Olivas, R. Orsoe, J. Osborn, E. O’Sullivan, H. Pandya, N. Park, G. K. Parker, E. N. Paudel, L. Paul, C. Pérez de los Heros, T. Pernice, J. Peterson, S. Philippen, A. Pizzuto, M. Plum, A. Pontén, Y. Popovych, M. Prado Rodriguez, B. Pries, R. Procter-Murphy, G. T. Przybylski, C. Raab, J. Rack-Helleis, M. Ravn, K. Rawlins, Z. Rechav, A. Rehman, P. Reichherzer, E. Resconi, S. Reusch, W. Rhode, B. Riedel, A. Rifaie, E. J. Roberts, S. Robertson, S. Rodan, G. Roellinghoff, M. Rongen, A. Rosted, C. Rott, T. Ruhe, L. Ruohan, D. Ryckbosch, I. Safa, J. Saffer, P. Sampathkumar, A. Sandrock, M. Santander, S. Sarkar, J. Savelberg, P. Savina, P. Schaile, M. Schaufel, H. Schieler, S. Schindler, B. Schlüter, F. Schlüter, N. Schmeisser, T. Schmidt, J. Schneider, F. G. Schröder, L. Schumacher, S. Sclafani, D. Seckel, M. Seikh, M. Seo, S. Seunarine, P. Sevle Myhr, R. Shah, S. Shefali, N. Shimizu, M. Silva, B. Skrzypek, B. Smithers, R. Snihur, J. Soedingrekso, A. Søgaard, D. Soldin, P. Soldin, G. Sommani, C. Spannfellner, G. M. Spiczak, C. Spiering, M. Stamatikos, T. Stanev, T. Stezelberger, T. Stürwald, T. Stuttard, G. W. Sullivan, I. Taboada, S. Ter-Antonyan, A. Terliuk, M. Thiesmeyer, W. G. Thompson, J. Thwaites, S. Tilav, C. Tönnis, S. Toscano, D. Tosi, A. Trettin, R. Turcotte, J. P. Twagirayezu, M. A. Unland Elorrieta, A. K. Upadhyay, K. Upshaw, A. Vaidyanathan, N. Valtonen-Mattila, J. Vandenbroucke, N. van Eijndhoven, D. Vannerom, J. van Santen, J. Vara, J. Veitch-Michaelis, M. Venugopal, M. Vereecken, S. Verpoest, D. Veske, A. Vijai, C. Walck, A. Wang, C. Weaver, P. Weigel, A. Weindl, J. Weldert, A. Y. Wen, C. Wendt, J. Werthebach, M. Weyrauch, N. Whitehorn, C. H. Wiebusch, D. R. Williams, L. Witthaus, A. Wolf, M. Wolf, G. Wrede, X. W. Xu, J. P. Yanez, E. Yildizci, S. Yoshida, R. Young, T. Yuan, Z. Zhang, P. Zhelnin, P. Zilberman, M. Zimmerman, and IceCube Collaboration
- Subjects
Neutrino astronomy ,Gamma-ray astronomy ,Particle astrophysics ,High energy astrophysics ,Astrophysics ,QB460-466 - Abstract
The origin of high-energy galactic cosmic rays is yet to be understood, but some galactic cosmic-ray accelerators can accelerate cosmic rays up to PeV energies. The high-energy cosmic rays are expected to interact with the surrounding material or radiation, resulting in the production of gamma-rays and neutrinos. To optimize for the detection of such associated production of gamma-rays and neutrinos for a given source morphology and spectrum, a multimessenger analysis that combines gamma-rays and neutrinos is required. In this study, we use the Multi-Mission Maximum Likelihood framework with IceCube Maximum Likelihood Analysis software and HAWC Accelerated Likelihood to search for a correlation between 22 known gamma-ray sources from the third HAWC gamma-ray catalog and 14 yr of IceCube track-like data. No significant neutrino emission from the direction of the HAWC sources was found. We report the best-fit gamma-ray model and 90% CL neutrino flux limit from the 22 sources. From the neutrino flux limit, we conclude that, for five of the sources, the gamma-ray emission observed by HAWC cannot be produced purely from hadronic interactions. We report the limit for the fraction of gamma-rays produced by hadronic interactions for these five sources.
- Published
- 2024
- Full Text
- View/download PDF
12. Telehealth treatment of patients with major depressive disorder during the COVID-19 pandemic: Comparative safety, patient satisfaction, and effectiveness to prepandemic in-person treatment
- Author
-
M. Zimmerman
- Subjects
Psychiatry ,RC435-571 - Abstract
Introduction The COVID-19 pandemic impelled a transition from in-person to telehealth psychiatric treatment. The COVID-19 pandemic has been depressogenic. Major disruptions in lifestyle due to social isolation, job loss, financial strain, and deaths of neighbors, family and friends are potential contributors to the increased levels of depression due to the pandemic. As one of the core elements of psychotherapeutic approaches towards treating depression is behavioral activation and increased social contact the psychosocial limitations imposed by COVID-19 might make it more difficult to treat depression during the pandemic. Objectives There are no studies of partial hospital telehealth treatment for major depressive disorder (MDD). In the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project, we compared the effectiveness of partial hospital care of patients with MDD treated virtually versus in-person. Methods Outcome was compared in 294 patients who were treated virtually from May, 2020 to December, 2021 to 542 patients who were treated in the in-person partial program in the 2 years prior to the pandemic. Patients completed self-administered measures of patient satisfaction, symptoms, coping ability, functioning, and general well-being. Results In both the in-person and telehealth groups patients with MDD were highly satisfied with treatment and reported a significant reduction in symptoms from admission to discharge. Both groups also reported a significant improvement in positive mental health, general well-being, coping ability, and functioning. A large effect size of treatment was found in both treatment groups. Contrary to our hypothesis, the small differences in outcome favored the telehealth-treated patients. The length of stay and the likelihood of staying in treatment until completion were significantly greater in the virtually treated patients. Conclusions In an intensive acute care setting, delivering treatment to patients with MDD using a virtual, telehealth platform was as effective as treating patients in-person. Disclosure of Interest None Declared
- Published
- 2023
- Full Text
- View/download PDF
13. 50% Improvement: Should Treatment Response Go Beyond Symptom Improvement When Evaluating the Treatment of Depression?
- Author
-
M. Zimmerman
- Subjects
Psychiatry ,RC435-571 - Abstract
Introduction The emphasis on symptom resolution in depression treatment research is at variance with the recommendations of official treatment guidelines and the results of surveys of depressed patients’ views of the most important treatment goals. Objectives In the present study, we examined the interrelationship between response rates on various outcome domains and whether response on each domain was associated with patients’ global rating of improvement (PGI) reported upon treatment completion. We also examined whether the PGI was associated with the number of domains on which the patients had achieved responder status and which domains were independent predictors of PGI response. Methods Eight hundred and forty-four patients with major depressive disorder completed the Remission from Depression Questionnaire (RDQ), a self-report measure that assesses 6 constructs considered by patients to be relevant to assessing treatment outcome. The patients completed the RDQ at admission and discharge from the treatment program. For each domain, response was defined as a 50% or greater reduction in scores. At discharge, the patients rated the PGI. Results The patients significantly improved from admission to discharge on each of the 6 domains assessed on the RDQ. The responders on each domain reported significantly greater improvement on the global rating of improvement at discharge. Responder status in one domain mostly co-occurred with responder status in another domain. In a logistic regression analysis, responses on all domains, except nondepressive symptoms, were independently associated with PGI response. Conclusions The results of the present study are consistent with multiple surveys which have suggested that focusing on symptom reduction is too narrow of an approach when measuring outcome in the treatment of depression. Expanding the assessment of outcome beyond symptoms and viewing nonsymptomatic outcome domains as critical composites of primary endpoints would be more consistent with a patient-centered approach towards the treatment of depression. Disclosure of Interest None Declared
- Published
- 2023
- Full Text
- View/download PDF
14. Search for Extended Sources of Neutrino Emission in the Galactic Plane with IceCube
- Author
-
R. Abbasi, M. Ackermann, J. Adams, S. K. Agarwalla, J. A. Aguilar, M. Ahlers, J. M. Alameddine, N. M. Amin, K. Andeen, G. Anton, C. Argüelles, Y. Ashida, S. Athanasiadou, S. N. Axani, X. Bai, A. Balagopal V., M. Baricevic, S. W. Barwick, V. Basu, R. Bay, J. J. Beatty, J. Becker Tjus, J. Beise, C. Bellenghi, C. Benning, S. BenZvi, D. Berley, E. Bernardini, D. Z. Besson, E. Blaufuss, S. Blot, F. Bontempo, J. Y. Book, C. Boscolo Meneguolo, S. Böser, O. Botner, J. Böttcher, E. Bourbeau, J. Braun, B. Brinson, J. Brostean-Kaiser, R. T. Burley, R. S. Busse, D. Butterfield, M. A. Campana, K. Carloni, E. G. Carnie-Bronca, S. Chattopadhyay, N. Chau, C. Chen, Z. Chen, D. Chirkin, S. Choi, B. A. Clark, L. Classen, A. Coleman, G. H. Collin, A. Connolly, J. M. Conrad, P. Coppin, P. Correa, D. F. Cowen, P. Dave, C. De Clercq, J. J. DeLaunay, D. Delgado, S. Deng, K. Deoskar, A. Desai, P. Desiati, K. D. de Vries, G. de Wasseige, T. DeYoung, A. Diaz, J. C. Díaz-Vélez, M. Dittmer, A. Domi, H. Dujmovic, M. A. DuVernois, T. Ehrhardt, P. Eller, E. Ellinger, S. El Mentawi, D. Elsässer, R. Engel, H. Erpenbeck, J. Evans, P. A. Evenson, K. L. Fan, K. Fang, K. Farrag, A. R. Fazely, A. Fedynitch, N. Feigl, S. Fiedlschuster, C. Finley, L. Fischer, D. Fox, A. Franckowiak, A. Fritz, P. Fürst, J. Gallagher, E. Ganster, A. Garcia, L. Gerhardt, A. Ghadimi, C. Glaser, T. Glauch, T. Glüsenkamp, N. Goehlke, J. G. Gonzalez, S. Goswami, D. Grant, S. J. Gray, O. Gries, S. Griffin, S. Griswold, K. M. Groth, C. Günther, P. Gutjahr, C. Haack, A. Hallgren, R. Halliday, L. Halve, F. Halzen, H. Hamdaoui, M. Ha Minh, K. Hanson, J. Hardin, A. A. Harnisch, P. Hatch, A. Haungs, K. Helbing, J. Hellrung, F. Henningsen, L. Heuermann, N. Heyer, S. Hickford, A. Hidvegi, C. Hill, G. C. Hill, K. D. Hoffman, S. Hori, K. Hoshina, W. Hou, T. Huber, K. Hultqvist, M. Hünnefeld, R. Hussain, K. Hymon, S. In, A. Ishihara, M. Jacquart, O. Janik, M. Jansson, G. S. Japaridze, M. Jeong, M. Jin, B. J. P. Jones, D. Kang, W. Kang, X. Kang, A. Kappes, D. Kappesser, L. Kardum, T. Karg, M. Karl, A. Karle, U. Katz, M. Kauer, J. L. Kelley, A. Khatee Zathul, A. Kheirandish, J. Kiryluk, S. R. Klein, A. Kochocki, R. Koirala, H. Kolanoski, T. Kontrimas, L. Köpke, C. Kopper, D. J. Koskinen, P. Koundal, M. Kovacevich, M. Kowalski, T. Kozynets, J. Krishnamoorthi, K. Kruiswijk, E. Krupczak, A. Kumar, E. Kun, N. Kurahashi, N. Lad, C. Lagunas Gualda, M. Lamoureux, M. J. Larson, S. Latseva, F. Lauber, J. P. Lazar, J. W. Lee, K. Leonard DeHolton, A. Leszczyńska, M. Lincetto, Q. R. Liu, M. Liubarska, E. Lohfink, C. Love, C. J. Lozano Mariscal, L. Lu, F. Lucarelli, W. Luszczak, Y. Lyu, J. Madsen, K. B. M. Mahn, Y. Makino, E. Manao, S. Mancina, W. Marie Sainte, I. C. Mariş, S. Marka, Z. Marka, M. Marsee, I. Martinez-Soler, R. Maruyama, F. Mayhew, T. McElroy, F. McNally, J. V. Mead, K. Meagher, S. Mechbal, A. Medina, M. Meier, Y. Merckx, L. Merten, J. Micallef, J. Mitchell, T. Montaruli, R. W. Moore, Y. Morii, R. Morse, M. Moulai, T. Mukherjee, R. Naab, R. Nagai, M. Nakos, U. Naumann, J. Necker, A. Negi, M. Neumann, H. Niederhausen, M. U. Nisa, A. Noell, A. Novikov, S. C. Nowicki, A. Obertacke Pollmann, V. O’Dell, M. Oehler, B. Oeyen, A. Olivas, R. Orsoe, J. Osborn, E. O’Sullivan, H. Pandya, N. Park, G. K. Parker, E. N. Paudel, L. Paul, C. Pérez de los Heros, J. Peterson, S. Philippen, A. Pizzuto, M. Plum, A. Pontén, Y. Popovych, M. Prado Rodriguez, B. Pries, R. Procter-Murphy, G. T. Przybylski, C. Raab, J. Rack-Helleis, K. Rawlins, Z. Rechav, A. Rehman, P. Reichherzer, G. Renzi, E. Resconi, S. Reusch, W. Rhode, B. Riedel, A. Rifaie, E. J. Roberts, S. Robertson, S. Rodan, G. Roellinghoff, M. Rongen, C. Rott, T. Ruhe, L. Ruohan, D. Ryckbosch, D. Rysewyk, I. Safa, J. Saffer, D. Salazar-Gallegos, P. Sampathkumar, S. E. Sanchez Herrera, A. Sandrock, M. Santander, S. Sarkar, J. Savelberg, P. Savina, M. Schaufel, H. Schieler, S. Schindler, L. Schlickmann, B. Schlüter, F. Schlüter, N. Schmeisser, T. Schmidt, J. Schneider, F. G. Schröder, L. Schumacher, G. Schwefer, S. Sclafani, D. Seckel, M. Seikh, S. Seunarine, R. Shah, A. Sharma, S. Shefali, N. Shimizu, M. Silva, B. Skrzypek, B. Smithers, R. Snihur, J. Soedingrekso, A. Søgaard, D. Soldin, P. Soldin, G. Sommani, C. Spannfellner, G. M. Spiczak, C. Spiering, M. Stamatikos, T. Stanev, T. Stezelberger, T. Stürwald, T. Stuttard, G. W. Sullivan, I. Taboada, S. Ter-Antonyan, M. Thiesmeyer, W. G. Thompson, J. Thwaites, S. Tilav, K. Tollefson, C. Tönnis, S. Toscano, D. Tosi, A. Trettin, C. F. Tung, R. Turcotte, J. P. Twagirayezu, B. Ty, M. A. Unland Elorrieta, A. K. Upadhyay, K. Upshaw, N. Valtonen-Mattila, J. Vandenbroucke, N. van Eijndhoven, D. Vannerom, J. van Santen, J. Vara, J. Veitch-Michaelis, M. Venugopal, M. Vereecken, S. Verpoest, D. Veske, A. Vijai, C. Walck, C. Weaver, P. Weigel, A. Weindl, J. Weldert, C. Wendt, J. Werthebach, M. Weyrauch, N. Whitehorn, C. H. Wiebusch, N. Willey, D. R. Williams, A. Wolf, M. Wolf, G. Wrede, X. W. Xu, J. P. Yanez, E. Yildizci, S. Yoshida, R. Young, F. Yu, S. Yu, T. Yuan, Z. Zhang, P. Zhelnin, M. Zimmerman, and IceCube Collaboration
- Subjects
Neutrino astronomy ,Astrophysics ,QB460-466 - Abstract
The Galactic plane, harboring a diffuse neutrino flux, is a particularly interesting target in which to study potential cosmic-ray acceleration sites. Recent gamma-ray observations by HAWC and LHAASO have presented evidence for multiple Galactic sources that exhibit a spatially extended morphology and have energy spectra continuing beyond 100 TeV. A fraction of such emission could be produced by interactions of accelerated hadronic cosmic rays, resulting in an excess of high-energy neutrinos clustered near these regions. Using 10 years of IceCube data comprising track-like events that originate from charged-current muon neutrino interactions, we perform a dedicated search for extended neutrino sources in the Galaxy. We find no evidence for time-integrated neutrino emission from the potential extended sources studied in the Galactic plane. The most significant location, at 2.6 σ post-trials, is a 1.°7 sized region coincident with the unidentified TeV gamma-ray source 3HWC J1951+266. We provide strong constraints on hadronic emission from several regions in the galaxy.
- Published
- 2023
- Full Text
- View/download PDF
15. Special Education Teacher Attrition and Retention in Rural and Suburban Schools in Southeastern Pennsylvania
- Author
-
Elizabeth M. Zimmerman
- Abstract
There are evident shortages with increased demands for qualified special education teachers (SETs) nationwide (Peyton et al., 2021). Although efforts have been made to reduce SET attrition and increase retention, it is still unknown what job factors influence SETs' intent to stay, transfer, migrate, pursue administrative positions, pursue positions in higher education, or leave education entirely (Mason-Williams et al., 2020; Peyton et al., 2021). A predictive correlational research design was used to perform a correlational analysis among SET job satisfaction and SET intent variables. A logistic regression analysis enhanced this research by providing a model that predicts SETs' specific intentions based on various job satisfaction factors. A multivariant analysis was also utilized to analyze the effects of job satisfaction on SET demographic subgroups. A total of 78 SETs in southeastern Pennsylvania participated in the research study completing a Likert-scaled, closed-ended quantitative survey regarding their job satisfaction in administrative support, job demands, and compensation, and their specific intentions regarding special education. All SET job satisfaction variables showed statistically significant correlations with SETs' intent to stay in the field. Compensation was the only job satisfaction variable with a statistically significant negative correlation with intent to transfer to general education and pursue an administrative position. Job satisfaction with administrative support indicated a statistically significant negative correlation with SETs' intention to leave education entirely. When logistic regression models were completed for SETs' intentions for all job satisfaction predictor variables, compensation was determined to be the only significant predictor variable for three specific outcome variables, including SETs' intent to stay in the field, transfer to general education, and pursue an administrative position. Additionally, there were no significant differences in job satisfaction among the variable groups for grade levels taught, teaching roles, or school district locale. Although Persistent SET shortages continue to compromise standards of a free appropriate public education (FAPE) for students with disabilities, the study's findings provided recommendations to help mitigate SET attrition and help retain special educators to benefit school districts and students in the ever-changing post-pandemic environment and offered suggestions for future research. [The dissertation citations contained here are published with the permission of ProQuest LLC. Further reproduction is prohibited without permission. Copies of dissertations may be obtained by Telephone (800) 1-800-521-0600. Web page: http://www.proquest.com/en-US/products/dissertations/individuals.shtml.]
- Published
- 2023
16. Real-world outcomes associated with afatinib use in patients with solid tumors harboring NRG1 gene fusions
- Author
-
Liu, Stephen V., Frohn, Claas, Minasi, Lori, Fernamberg, Kristie, Klink, Andrew J., Gajra, Ajeet, Savill, Kristin M. Zimmerman, and Jonna, Sushma
- Published
- 2024
- Full Text
- View/download PDF
17. Large-Scale Materials Modeling at Quantum Accuracy: Ab Initio Simulations of Quasicrystals and Interacting Extended Defects in Metallic Alloys.
- Author
-
Sambit Das, Bikash Kanungo, Vishal Subramanian, Gourab Panigrahi, Phani Motamarri, David M. Rogers 0001, Paul M. Zimmerman, and Vikram Gavini
- Published
- 2023
- Full Text
- View/download PDF
18. Learning local and semi-local density functionals from exact exchange-correlation potentials and energies.
- Author
-
Bikash Kanungo, Jeffrey Hatch, Paul M. Zimmerman, and Vikram Gavini
- Published
- 2024
- Full Text
- View/download PDF
19. Machine Learning Strategies for Reaction Development: Toward the Low-Data Limit.
- Author
-
Eunjae Shim, Ambuj Tewari, Tim Cernak, and Paul M. Zimmerman
- Published
- 2023
- Full Text
- View/download PDF
20. What's the Fuss: The Excitement, Prospects and Software/Hardware Challenges of Distributing Entanglement over a Quantum Network.
- Author
-
Neil M. Zimmerman
- Published
- 2022
21. Conformer-RL: A deep reinforcement learning library for conformer generation.
- Author
-
Runxuan Jiang, Tarun Gogineni, Joshua Kammeraad, Yifei He, Ambuj Tewari, and Paul M. Zimmerman
- Published
- 2022
- Full Text
- View/download PDF
22. The numerical evaluation of Slater integrals on graphics processing units.
- Author
-
Duy-Khoi Dang, Leighton Wilson, and Paul M. Zimmerman
- Published
- 2022
- Full Text
- View/download PDF
23. Massively parallel quantum chemistry: PFAS on over 1 million cloud vCPUs.
- Author
-
Alan E. Rask, Lee Huntington, SungYeon Kim, David Walker 0006, Andrew Wildman, Rodrigo Wang, Nicole Hazel, Alan Judi, James T. Pegg, Punit K. Jha, Zara Mayimfor, Carl Dukatz, Hassan Naseri, Ilan Gleiser, Maxime R. Hugues, Paul M. Zimmerman, Arman Zaribafiyan, Rudi Plesch, and Takeshi Yamazaki
- Published
- 2023
- Full Text
- View/download PDF
24. Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitors
- Author
-
Savill, Kristin M. Zimmerman, Lee, Brian B., Oeh, Jason, Lin, Jie, Lin, Eva, Chung, Wei-Jen, Young, Amy, Chen, Wennie, Miś, Monika, Mesh, Kathryn, Eastham, Jeffrey, Gnad, Florian, Jiang, Zhaoshi, Stawiski, Eric W., Haley, Benjamin, Daemen, Anneleen, Wang, Xiaojing, Koeppen, Hartmut, Modrusan, Zora, Martin, Scott E., Sampath, Deepak, and Lin, Kui
- Published
- 2022
- Full Text
- View/download PDF
25. Biomarker testing and adjuvant osimertinib use in patients with resectable EGFR-mutated stage IB–IIIA NSCLC: Physician practices, therapy choice, and barriers among US oncologists.
- Author
-
Aggarwal, Puja, primary, Savill, Kristin M. Zimmerman, additional, Jeune-Smith, Yolaine, additional, Jennings-Zhang, Luke, additional, Bone, Robert, additional, Kelly, Ronan Joseph, additional, and Feinberg, Bruce A., additional
- Published
- 2024
- Full Text
- View/download PDF
26. Development of a novel methodology to assess response to lymphoma treatment in real-world data.
- Author
-
Klink, Andrew J., primary, Swain, Richard Scott, additional, Savill, Kristin M. Zimmerman, additional, Kalesan, Bindu, additional, Asgarisabet, Parisa, additional, Balanean, Alexandrina, additional, Hays, Harlen, additional, Kaufman, Jill, additional, McAllister, Lindsay, additional, Yu, Hsing-Ting, additional, Laney, Jalyna R., additional, Richardson, Nicholas C., additional, Lerro, Catherine C., additional, Rizvi, Fatima, additional, Vallejo, Jonathon, additional, Wang, Kun, additional, Theoret, Marc R., additional, Rivera, Donna, additional, and Feinberg, Bruce A., additional
- Published
- 2024
- Full Text
- View/download PDF
27. Posterior Torso and Buttocks Contour Enhancement
- Author
-
M. Zimmerman, Edward, primary
- Published
- 2022
- Full Text
- View/download PDF
28. Adaptive Sampling for Discovery.
- Author
-
Ziping Xu, Eunjae Shim, Ambuj Tewari, and Paul M. Zimmerman
- Published
- 2022
29. Formal Verification of Flow Equivalence in Desynchronized Designs.
- Author
-
Jennifer Paykin, Brian Huffman, Daniel M. Zimmerman, and Peter A. Beerel
- Published
- 2020
- Full Text
- View/download PDF
30. Adaptive Learning for Discovery.
- Author
-
Ziping Xu, Eunjae Shim, Ambuj Tewari, and Paul M. Zimmerman
- Published
- 2022
- Full Text
- View/download PDF
31. What Does the Machine Learn? Knowledge Representations of Chemical Reactivity.
- Author
-
Joshua Kammeraad, Jack Goetz, Eric Walker, Ambuj Tewari, and Paul M. Zimmerman
- Published
- 2020
- Full Text
- View/download PDF
32. Formal Cross-Coupling of Amines and Carboxylic Acids to Form sp3–sp2 Carbon–Carbon Bonds
- Author
-
James L. Douthwaite, Ruheng Zhao, Eunjae Shim, Babak Mahjour, Paul M. Zimmerman, and Tim Cernak
- Subjects
Colloid and Surface Chemistry ,General Chemistry ,Biochemistry ,Catalysis - Published
- 2023
- Full Text
- View/download PDF
33. Active Learning for Non-Parametric Regression Using Purely Random Trees.
- Author
-
Jack Goetz, Ambuj Tewari, and Paul M. Zimmerman
- Published
- 2018
34. Reasoning About Disagreements: Instructional Design to Improve Thinking About Controversial Multiple Documents.
- Author
-
Toshio Mochizuki, Clark A. Chinn, Randi M. Zimmerman, and Etsuji Yamaguchi
- Published
- 2020
35. Epistemic Injustices Obstruct Reliable Epistemic Practices.
- Author
-
Randi M. Zimmerman and Clark A. Chinn
- Published
- 2020
36. TorsionNet: A Reinforcement Learning Approach to Sequential Conformer Search.
- Author
-
Tarun Gogineni, Ziping Xu, Exequiel Punzalan, Runxuan Jiang, Joshua Kammeraad, Ambuj Tewari, and Paul M. Zimmerman
- Published
- 2020
37. Learning To Predict Reaction Conditions: Relationships between Solvent, Molecular Structure, and Catalyst.
- Author
-
Eric Walker, Joshua Kammeraad, Jonathan Goetz, Michael T. Robo, Ambuj Tewari, and Paul M. Zimmerman
- Published
- 2019
- Full Text
- View/download PDF
38. Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast Cancer
- Author
-
Kristin M Zimmerman Savill, Jasmina Ivanova, Parisa Asgarisabet, Angelica Falkenstein, Alexandrina Balanean, Alexander Niyazov, Joanne C Ryan, Jonathan Kish, Ajeet Gajra, and Reshma L Mahtani
- Subjects
Cancer Research ,Oncology - Abstract
Background Talazoparib is a poly (adenosine diphosphate-ribose) polymerase inhibitor approved for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), HER2-negative, locally advanced or metastatic breast cancer (LA/mBC), with approval based on the EMBRACA trial. To date, there are no published data on talazoparib use in the real-world United States (USA) setting. Patients and Methods Characteristics, treatment patterns, and clinical outcomes of real-world US patients with gBRCAm HER2-negative LA/mBC treated with talazoparib monotherapy were collected via retrospective chart review and summarized using descriptive statistics. Results Among 84 eligible patients, 35.7% had hormone receptor-positive tumors and 64.3% had triple-negative LA/mBC (TNBC). At talazoparib initiation, 29.8% had ECOG PS of ≥2 and 19.0% had brain metastasis. Mutations in gBRCA1 or 2 were detected among 64.3% and 35.7% of patients, respectively. Talazoparib was given as 1st-line therapy in 14.3% of patients, 2nd-line in 40.5%, and 3rd- or 4th-line in 45.2%. Median time to talazoparib treatment failure was 8.5 months (95% CI, 8.0-9.7), median progression-free survival was 8.7 months (95% CI, 8.0-9.9), the median time from initiation to chemotherapy was 12.2 months (95% CI, 10.5-20.1), and the overall response rate was 63.1%. No differences in clinical outcomes were observed between patients with HR-positive/HER2-negative LA/mBC and patients with TNBC by using unadjusted statistical comparisons. Brain metastasis and ECOG PS ≥2 at talazoparib initiation were associated with treatment failure and progression or mortality. Conclusion Overall, talazoparib clinical outcomes in this real-world population are consistent with findings from EMBRACA.
- Published
- 2023
- Full Text
- View/download PDF
39. Examining Differences in the Individual and Contextual Risk Factors for Police Officer, Correctional Officer, and Non-Protective Service Suicides
- Author
-
Gregory M. Zimmerman, Emma E. Fridel, and Natasha A. Frost
- Subjects
Law ,Pathology and Forensic Medicine - Published
- 2023
- Full Text
- View/download PDF
40. Response to Tyrosine Kinase Inhibitors in Patients with BCR-ABL1 Positive Chronic Myeloid Leukemia; 13.5 Years’ Experience at Patan Hospital, Nepal
- Author
-
A. Adhikari, K. Shrish, G. K. Kayastha, N. Ranjitkar, M. Zimmerman, M. Lama, R. K. Thapa, and B. Basnyat
- Subjects
General Medicine - Abstract
Background: Since the advent of Tyrosine Kinase Inhibitor (TKI), well controlled studies in developed world have shown that the life expectancy of patients with CML is comparable to normal people without the disease. But long-term follow up studies are lacking in resource poor setting. Methods: This is a retrospective follow up study looking at the molecular response and resistance to Tyrosine Kinase Inhibitors (TKI) in patients enrolled in the Max Access Program since February 2003 till March 2017. Patients with two or more BCR-ABL1 levels by Karyotyping/ fluorescent in situ hybridization (FISH) / reverse transcriptase polymerase chain reaction (RT-PCR) were included. At baseline, complete blood count (CBC), renal function test (RFT), and liver function test (LFT) were evaluated. Bone marrow aspiration and biopsy for morphology, cytogenetic analysis by Karyotyping/FISH and/or molecular analysis by RT-PCR were also done if these tests were not performed earlier. FISH or RT-PCR was done on peripheral blood every 3–12 months as necessary if the patient could afford. Patients with warning response/failure underwent BCR-ABL1 Resistance Mutation Analysis (IRMA). Results: Three hundred and forty six (346) patients had two or more BCR-ABL1 monitoring tests done. Optimal response was seen in 49.42%. Similarly, suboptimal response and failure were seen in 16.5% and 34% respectively. Overall Survival is 89.6% (at 1.8 -165 months, mean 62 months) . If only CML related events is considered survival is 95.9%. Seventy seven (77) patients with a total of 80 BCR-ABL1 domain Imatinib Resistance Mutation Analyses (IRMA) showed 19 different types of mutations with the most common being T315I mutation (8 and 19.5%). About 22.25% of the total patients showed resistance to Glivec out of which 10.98% showed mutations. Nine patients underwent trial for treatment free response (TFR) and 5 of them relapsed between 2-8 months. Conclusions: Despite all the odds of having financial problem, accessibility problem due to distances, transportation, etc. and difficulty monitoring with routine BCR-ABL1 and IRMA, our findings show that the outcome of TKI therapy in our CML patients is comparable to well controlled studies done elsewhere. Overall survival, molecular and cytogenetic responses and mutations in our patients who developed resistance as well as TFR are also similar to other studies. The resistance rate of 22.25% is slightly higher compared to other studies in developed world. This is mainly because of poor monitoring due to unavailability of the test including IRMA in our country and affordability until 2012. It proves that TKI is very effective in CML even in a resource-poor, developing country.
- Published
- 2023
- Full Text
- View/download PDF
41. Digitizing a Therapeutic: Development of an Augmented Reality Dual-Task Training Platform for Parkinson's Disease.
- Author
-
Jay L. Alberts, Ryan D. Kaya, Kathryn Scelina, Logan Scelina, Eric M. Zimmerman, Benjamin L. Walter, and Anson B. Rosenfeldt
- Published
- 2022
- Full Text
- View/download PDF
42. Stepwise basis set selection.
- Author
-
Maxwell W. Li and Paul M. Zimmerman
- Published
- 2018
- Full Text
- View/download PDF
43. Virtual Screening of Hole Transport, Electron Transport, and Host Layers for Effective OLED Design.
- Author
-
Shao-Yu Lu, Sukrit Mukhopadhyay, Robert Froese, and Paul M. Zimmerman
- Published
- 2018
- Full Text
- View/download PDF
44. Rethinking Catalyst Trapping in Ni-Catalyzed Thieno[3,2-b]thiophene Polymerization
- Author
-
Matthew D. Hannigan, Jessica L. Tami, Paul M. Zimmerman, and Anne J. McNeil
- Subjects
Inorganic Chemistry ,Polymers and Plastics ,Organic Chemistry ,Materials Chemistry - Published
- 2022
- Full Text
- View/download PDF
45. A taxometric approach to base-rate estimation and idiographic classification in psycholegal research
- Author
-
Dario N. Rodriguez and David M. Zimmerman
- Subjects
Psychiatry and Mental health ,Arts and Humanities (miscellaneous) ,Law ,General Psychology - Abstract
Taxometric analysis employs multiple, nonoverlapping statistical procedures to estimate parameters that characterize latent categories (e.g., base rates). Consistency among these estimates can inform substantive inferences about latent variables and facilitate idiographic classification. We provide a sketch of a taxometric research program to estimate guilty-suspect base rates in criminal justice and legal systems and use this sketch to explore the possible benefits of taxometric investigations for science and public policy.We investigated whether taxometric analysis can accurately estimate base rates and facilitate idiographic classifications under conditions psycholegal researchers might face.We demonstrate taxometric analysis on simulated data to detect latent categories, estimate their base rates, and classify individual cases.Our simulations show that taxometric analysis can accurately estimate taxon base rates. Specifically, estimated base rates differed from simulated base rates by less than 3%. Further, idiographic classification rules derived from taxometric analysis accurately classified individual cases in additional data sets, with positive predictive values and negative predictive values exceeding .85.If legal categories of interest represent nonarbitrary classes, taxometric methods afford an analytic approach by which researchers can use fallible indicator variables to estimate their base rates and develop algorithms for legal classification. We discuss potential objections to the taxometric approach and identify important avenues for future research and development in psycholegal applications of taxometric methods. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
- Published
- 2022
- Full Text
- View/download PDF
46. Ezh2Y641F mutations co-operate with Stat3 to regulate MHC class I antigen processing and alter the tumor immune response in melanoma
- Author
-
Sarah M. Zimmerman, Samantha J. Nixon, Pei Yu Chen, Leela Raj, Sofia R. Smith, Rachel L. Paolini, Phyo Nay Lin, and George P. Souroullas
- Subjects
Cancer Research ,Genetics ,Molecular Biology - Published
- 2022
- Full Text
- View/download PDF
47. Utilization and Effect of Direct Medical Oversight during Out-of-Hospital Cardiac Arrest
- Author
-
Tristen M. Zimmerman, Matthew R. Neth, Mary E. Tanski, Laura Chess, Kathryn Thompson, Jonathan Jui, Ritu Sahni, Mohamud R. Daya, and Joshua R. Lupton
- Subjects
Emergency Medicine ,Emergency Nursing - Abstract
Direct medical oversight (DMO), where emergency medical services (EMS) clinicians contact a physician for real-time medical direction, is used by many EMS systems across the United States. Our objective was to characterize the recommendations made by DMO during out-of-hospital cardiac arrests (OHCA) and to determine their effect on EMS transport decisions and patient outcomes. This is a secondary analysis of DMO call recordings from OHCA cases in the Portland, Oregon metropolitan area from January 1, 2018 to February 28, 2021. Data extracted from the audio recordings were linked to OHCA cases in the Portland Cardiac Arrest Epidemiologic Registry (PDX Epistry). The primary outcomes are recommendations made by DMO: transport, continued field resuscitation, or termination of resuscitation (TOR). Secondary outcomes include EMS transport decisions, survival to hospital admission, and survival to hospital discharge. We used descriptive statistics, unpaired t-tests, and chi-square tests as appropriate for data analysis. There were 239 OHCA cases for which DMO was contacted by EMS. The median time from EMS arrival to DMO contact was 25.6 min, and EMS requested TOR for 72.0% of patients. Compared to patients where EMS requested further treatment advice, patients for whom EMS requested TOR had poor prognostic signs including older age, asystole as an initial rhythm, and lower rates of transient return of spontaneous circulation prior to DMO call compared with cases where EMS did not request TOR. DMO recommended transport, continued field resuscitation, or TOR in 21.8%, 18.0%, and 60.2% of patients, respectively. Of the 239 patients, 59 (24.7%) were ultimately transported by EMS to the hospital, 14 (5.9%) survived to admission, and only 1 patient (0.4%) survived to hospital discharge and had an acceptable neurologic outcome (Cerebral Performance Category score of 2). Patients for whom EMS contacts DMO for further treatment advice or requesting field TOR after prolonged OHCA resuscitation have poor outcomes, even when DMO recommends transport or further resuscitation, and may represent opportunities to reduce unnecessary DMO contact or patient transports. More research is needed to determine which OHCA patients benefit from DMO contact.
- Published
- 2022
- Full Text
- View/download PDF
48. Activation Mechanism of Nickel(0) N-Heterocyclic Carbene Catalysts Stabilized by Fumarate Ligands
- Author
-
Ellen Butler, John Montgomery, Amie Frank, Michael T. Robo, Paul M. Zimmerman, Alex J. Nett, and Santiago Cañellas
- Subjects
inorganic chemicals ,Ligand ,Chemistry ,Organic Chemistry ,chemistry.chemical_element ,Combinatorial chemistry ,Article ,Catalysis ,Inorganic Chemistry ,Nickel ,chemistry.chemical_compound ,Mechanism (philosophy) ,Covalent bond ,Physical and Theoretical Chemistry ,Carbene ,Stoichiometry - Abstract
Nickel(0) catalysts of N-heterocyclic carbenes (NHCs) that are stabilized by electron-deficient alkenes possess desirable properties of air tolerance and ease of handling while also retaining high catalytic activities. Since catalyst stability often comes at the expense of catalytic activity, we have undertaken a detailed study of the activation mechanism of an IMes-nickel(0) catalyst stabilized by di(o-tolyl) fumarate that converts the stable precatalyst form into a catalytically active species. Computational evaluation provided evidence against a simple ligand exchange as the activation mechanism for this catalyst, and a stoichiometric activation process that covalently modifies the stabilizing ligand was identified. A detailed computational picture for the activation process was developed, with predictive insights that elucidate an unexpected catalyst activation pathway that operates when ligand exchange is thermodynamically unfavorable.
- Published
- 2022
- Full Text
- View/download PDF
49. <scp>Conformer‐RL</scp> : A deep reinforcement learning library for conformer generation
- Author
-
Runxuan Jiang, Tarun Gogineni, Joshua Kammeraad, Yifei He, Ambuj Tewari, and Paul M. Zimmerman
- Subjects
Computational Mathematics ,Polymers ,Molecular Conformation ,Neural Networks, Computer ,General Chemistry ,Reinforcement, Psychology ,Algorithms - Abstract
Conformer-RL is an open-source Python package for applying deep reinforcement learning (RL) to the task of generating a diverse set of low-energy conformations for a single molecule. The library features a simple interface to train a deep RL conformer generation model on any covalently bonded molecule or polymer, including most drug-like molecules. Under the hood, it implements state-of-the-art RL algorithms and graph neural network architectures tuned specifically for molecular structures. Conformer-RL is also a platform for researching new algorithms and neural network architectures for conformer generation, as the library contains modular class interfaces for RL environments and agents, allowing users to easily swap components with their own implementations. Additionally, it comes with tools to visualize and save generated conformers for further analysis. Conformer-RL is well-tested and thoroughly documented with tutorials for each of the functionalities mentioned above, and is available on PyPi and Github: https://github.com/ZimmermanGroup/conformer-rl.
- Published
- 2022
- Full Text
- View/download PDF
50. Glycosyl Exchange of Unactivated Glycosidic Bonds: Suppressing or Embracing Side Reactivity in Catalytic Glycosylations
- Author
-
Joshua L. Martin, Girish C. Sati, Tanmay Malakar, Jessica Hatt, Paul M. Zimmerman, and John Montgomery
- Subjects
Glycosylation ,Organic Chemistry ,Stereoisomerism ,Glycosides ,Catalysis ,Article ,Ethers - Abstract
While developing boron-catalyzed glycosylations using glycosyl fluoride donors and trialkylsilyl ether acceptors, competing pathways involving productive glycosylation or glycosyl exchange were observed. Experimental and computational mechanistic studies suggest a novel mode of reactivity where a dioxolenium ion is a key intermediate that promotes both pathways through addition to either a silyl ether or to the acetal of an existing glycosidic linkage. Modifications in catalyst structure enable either pathway to be favored, and with this understanding, improved multicomponent iterative couplings and glycosyl exchange processes were demonstrated.
- Published
- 2023
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.